DJIA 17,020.84 -77.61 -0.45%
NASDAQ 4,577.67 -2.60 -0.06%
S&P 500 1,996.40 -6.97 -0.35%
market minute promo

Novartis (NYSE: NVS)

93.55 3.71 (4.13%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

NVS $93.55 4.13%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $92.95
Previous Close $89.84
Daily Range $92.87 - $93.58
52-Week Range $72.62 - $93.58
Market Cap $227.0B
P/E Ratio 24.28
Dividend (Yield) $2.72 (2.6%)
Ex-Dividend Date
Dividend Pay Date
02/27/14
04/10/14
Volume 4,509,490
Average Daily Volume 973,440
Current FY EPS $5.19

Sector

Healthcare

Industry

Drugs

Novartis (NVS) Description

Operates in the business of patent-protected and generic pharmaceuticals as well as consumer health products. Website: http://www.novartis.com/

News & Commentary

Why Google Wants to Map Your Body With Its Baseline Study

Google recently announced that it will collect genetic information from thousands of people to “map out” the healthy human body. Here’s what you need to know about the Google Baseline Study.

Benzinga's Volume Movers

Why Novartis AG (NVS) Stock Is Climbing Today

Shire plc (SHPG) Ex-Dividend Date Scheduled for September 03, 2014

Heavy Trading On Novartis (NVS) Before Market Open

Sector Update: Health Care Shares Flat Pre-Market

Novartis up, Iliad drops: European movers

Momenta-Sandoz's Generic Copaxone Accepted for Review by FDA - Analyst Blog

Why United Therapeutics Corporation Stock Skyrocketed

United Therapeutics stock is among today's top gainers after it announces a favorable legal ruling regarding its best-selling drug, Remodulin.

Is GlaxoSmithKline A Solid Long-Term Investment?

See More NVS News...

NVS's Top Competitors

NVS $93.55 (4.13%)
Current stock: NVS
JNJ $103.13 (-0.58%)
Current stock: JNJ
MRK $59.85 (-0.43%)
Current stock: MRK
GSK $48.18 (-1.87%)
Current stock: GSK